Literature DB >> 36090700

Considerations of biomarker application for cancer continuum in the era of precision medicine.

Rayjean J Hung1,2, Elham Khodayari Moez1, Shana J Kim2, Sanjeev Budhathoki1, Jennifer D Brooks2.   

Abstract

Purpose of the review: The goal of this review is to highlight emerging biomarker research by the key phases of the cancer continuum and outline the methodological considerations for biomarker application. Recent findings: While biomarkers have an established role in targeted therapy and to some extent, disease monitoring, their role in early detection and survivorship remains to be elucidated. With the advent of omics technology, the discovery of biomarkers has been accelerated exponentially, therefore careful consideration to ensure an unbiased study design and robust validity is crucial. Summary: The rigor of biomarker research holds the key to the success of precision health care. The potential clinical utility and the feasibility of implementation should be central to future biomarker research study design.

Entities:  

Keywords:  Biomarker; Cancer; Early detection; Precision medicine; Prognosis; Survivorship

Year:  2022        PMID: 36090700      PMCID: PMC9454320          DOI: 10.1007/s40471-022-00295-8

Source DB:  PubMed          Journal:  Curr Epidemiol Rep


  92 in total

1.  Guidelines for the Preanalytical Conditions for Analyzing Circulating Cell-Free DNA.

Authors:  Romain Meddeb; Ekaterina Pisareva; Alain R Thierry
Journal:  Clin Chem       Date:  2019-02-21       Impact factor: 8.327

Review 2.  Application of Cell-free DNA Analysis to Cancer Treatment.

Authors:  Ryan B Corcoran; Bruce A Chabner
Journal:  N Engl J Med       Date:  2018-11-01       Impact factor: 91.245

Review 3.  Ethical challenges of precision cancer medicine.

Authors:  Eva Caroline Winkler; Bartha Maria Knoppers
Journal:  Semin Cancer Biol       Date:  2020-10-09       Impact factor: 17.012

4.  Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab.

Authors:  Bonnie Ky; Mary Putt; Heloisa Sawaya; Benjamin French; James L Januzzi; Igal A Sebag; Juan Carlos Plana; Victor Cohen; Jose Banchs; Joseph R Carver; Susan E Wiegers; Randolph P Martin; Michael H Picard; Robert E Gerszten; Elkan F Halpern; Jonathan Passeri; Irene Kuter; Marielle Scherrer-Crosbie
Journal:  J Am Coll Cardiol       Date:  2013-11-27       Impact factor: 24.094

5.  The 100 000 Genomes Project: bringing whole genome sequencing to the NHS.

Authors:  Clare Turnbull; Richard H Scott; Ellen Thomas; Louise Jones; Nirupa Murugaesu; Freya Boardman Pretty; Dina Halai; Emma Baple; Clare Craig; Angela Hamblin; Shirley Henderson; Christine Patch; Amanda O'Neill; Katherine Smith; Antonio Rueda Martin; Alona Sosinsky; Ellen M McDonagh; Razvan Sultana; Michael Mueller; Damian Smedley; Adam Toms; Lisa Dinh; Tom Fowler; Mark Bale; Tim Hubbard; Augusto Rendon; Sue Hill; Mark J Caulfield
Journal:  BMJ       Date:  2018-04-24

Review 6.  The Application of Bayesian Methods in Cancer Prognosis and Prediction.

Authors:  Jiadong Chu; N A Sun; Wei Hu; Xuanli Chen; Nengjun Yi; Yueping Shen
Journal:  Cancer Genomics Proteomics       Date:  2022 Jan-Feb       Impact factor: 4.069

7.  Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability.

Authors:  Erika Assarsson; Martin Lundberg; Göran Holmquist; Johan Björkesten; Stine Bucht Thorsen; Daniel Ekman; Anna Eriksson; Emma Rennel Dickens; Sandra Ohlsson; Gabriella Edfeldt; Ann-Catrin Andersson; Patrik Lindstedt; Jan Stenvang; Mats Gullberg; Simon Fredriksson
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

8.  AHRR (cg05575921) hypomethylation marks smoking behaviour, morbidity and mortality.

Authors:  Stig E Bojesen; Nicholas Timpson; Caroline Relton; George Davey Smith; Børge G Nordestgaard
Journal:  Thorax       Date:  2017-01-18       Impact factor: 9.139

Review 9.  Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery.

Authors:  Yang Woo Kwon; Han-Seul Jo; Sungwon Bae; Youngsuk Seo; Parkyong Song; Minseok Song; Jong Hyuk Yoon
Journal:  Front Med (Lausanne)       Date:  2021-09-22

10.  Proteogenomics connects somatic mutations to signalling in breast cancer.

Authors:  Philipp Mertins; D R Mani; Kelly V Ruggles; Michael A Gillette; Karl R Clauser; Pei Wang; Xianlong Wang; Jana W Qiao; Song Cao; Francesca Petralia; Emily Kawaler; Filip Mundt; Karsten Krug; Zhidong Tu; Jonathan T Lei; Michael L Gatza; Matthew Wilkerson; Charles M Perou; Venkata Yellapantula; Kuan-lin Huang; Chenwei Lin; Michael D McLellan; Ping Yan; Sherri R Davies; R Reid Townsend; Steven J Skates; Jing Wang; Bing Zhang; Christopher R Kinsinger; Mehdi Mesri; Henry Rodriguez; Li Ding; Amanda G Paulovich; David Fenyö; Matthew J Ellis; Steven A Carr
Journal:  Nature       Date:  2016-05-25       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.